Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Liposomal Bupivacaine (Exparel) In Expedited Recovery Following Lower Extremity Amputation

NCT04360421 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT04360421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Liposomal Bupivacaine (Exparel) In Expedited Recovery Following Lower Extremity Amputation
Lead sponsor
Loma Linda University
Phase
Phase 4
Overall status
Terminated
Start date
April 21, 2020
Completion date
August 1, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amputation, anesthesia, local, opioid use